➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Boehringer Ingelheim
McKinsey
Johnson and Johnson
Dow

Last Updated: July 26, 2021

DrugPatentWatch Database Preview

ANTIVERT Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Antivert, and what generic alternatives are available?

Antivert is a drug marketed by Casper Pharma Llc and is included in one NDA.

The generic ingredient in ANTIVERT is meclizine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the meclizine hydrochloride profile page.

Summary for ANTIVERT
Drug patent expirations by year for ANTIVERT
Recent Clinical Trials for ANTIVERT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Duke UniversityPhase 2
Philip Morris USA, Inc.Phase 2
Lehigh Valley HospitalN/A

See all ANTIVERT clinical trials

Pharmacology for ANTIVERT
Drug ClassAntiemetic
Physiological EffectEmesis Suppression

US Patents and Regulatory Information for ANTIVERT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET, CHEWABLE;ORAL 010721-005 Approved Prior to Jan 1, 1982 AA RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET;ORAL 010721-001 Jan 20, 1982 AA RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET;ORAL 010721-006 Approved Prior to Jan 1, 1982 AA RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET;ORAL 010721-004 Approved Prior to Jan 1, 1982 AA RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Boehringer Ingelheim
McKinsey
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.